← Return to Just approved: Evusheld for the pre-exposure prevention of COVID-19
DiscussionJust approved: Evusheld for the pre-exposure prevention of COVID-19
Transplants | Last Active: Aug 19, 2022 | Replies (173)Comment receiving replies
Replies to "Astrazenica 's Evusheld has been approved for release and is being sent to State Health Departments..."
My concern is whether these monoclonal antibodies against the spike protein will worsen my existing autoimmune reaction caused by the Pfizer vaccine. Published research indicates I likely still have spike protein, which was produced by the vaccine, in my white blood cells. That spike protein is the target for the monoclonal antibodies in Evusheld. I talked to my rheumatologist about this issue and she said no one knows how I would react to the Evusheld product (another Emergency Use Authorization). A note of caution for the thousands of us who experienced severe adverse reactions to the Covid vaccines.